Liver fibrosis: cellular mechanisms of progression and resolution
The DOI matches its Crossref record; 137 of the 139 references it cites were found in a registry or an index.
Abstract
Liver fibrosis represents a major worldwide health care burden. The last 15 years have seen a rapid growth in our understanding of the pathogenesis of this clinically relevant model of inflammation and repair. This work is likely to inform the design of effective antifibrotic therapies in the near future. In this review, we examine how the innate and adaptive immune response interacts with other key cell types in the liver, such as the myofibroblast, regulating the process of hepatic fibrosis and, where relevant, resolution of fibrosis with remodelling. Emphasis is placed on the increasing knowledge that has been generated by the use of transgenic animals and animals in which specific cell lines have been deleted. Additionally, we review the increasing evidence that, although significant numbers of wound-healing myofibroblasts are derived from the hepatic stellate cell, significant contributions may occur from other cell lineages, including those from distant sites such as bone marrow stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, liver fibrosis is now recognized as a potentially reversible process, with resolution being closely linked to the reprogramming of macrophages towards restorative phenotypes characterized by enhanced efferocytosis, reduced pro-inflammatory signaling, and increased matrix degradation capacity.”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [88]
In the citing paper
“Resolution of fibrosis involves not only the degradation of ECM but also reprogramming of the immune microenvironment (87, 88).”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [88]
In the citing paper
“Fibrosis is regulated by an intricate interplay between TGF‐β pro‐fibrotic and TNF‐α anti‐fibrotic signaling pathways”
From p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling (2017) · cites this paper as Henderson & Iredale, 2007
Citations
Cites
1 retracted
RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro
Yao, H.-W., Xie, Q.-M., Chen, J., Deng, Y., & Tang, H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.019 · Cited by 109
RetractedAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“Duffield et al. (2005) [4]”
Self-citationEvidence that fibroblasts derive from epithelium during tissue fibrosis
Iwano, M., Plieth, D., Danoff, T. M., Xue, C., Okada, H., & Neilson, E. G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215518 · Cited by 1,590
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.
(1975) · PubMed Central · Cited by 1,437
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Cited by
Items 101–200 of 270
Study on antifibrotic effects of curcumin in rat hepatic stellate cells
Lin, Y., Lin, C., Chi, C., & Huang, Y. (2009) · Phytotherapy Research · doi:10.1002/ptr.2764 · Cited by 47
Wu, Y., Bu, F., Yu, H., Li, W., Huang, C., Meng, X., Zhang, L., Ma, T., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.002 · Cited by 49
Stine, J. G., Wang, J., Cornella, S. L., Behm, B. W., Henry, Z. H., Shah, N. L., Caldwell, S. H., & Northup, P. G. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8661 · Cited by 45
Matrix Metalloproteinases and Their Inhibitors
Campana, L., & Iredale, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00007-5 · Cited by 45
Self-citationGene Modulation for Treating Liver Fibrosis
Cheng, K., & Mahato, R. I. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i2.10 · Cited by 47
Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice
Sha, M., Gao, Y., Deng, C., Wan, Y., Zhuang, Y., Hu, X., & Wang, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106157 · Cited by 42
Th17 Down-regulation Is Involved in Reduced Progression of Schistosomiasis Fibrosis in ICOSL KO Mice
Wang, B., Song, L., Wang, Y., Zhu, X.-Q., Gong, W., Zhang, H.-Q., Li, Y., & Xia, C.-M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003434 · Cited by 45
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Sabir, U., Gu, H., & Zhang, D. (2023) · Phytotherapy Research · doi:10.1002/ptr.7959 · Cited by 43
Kumar, P., Smith, T., Rahman, K., Mells, J. E., Thorn, N. E., Saxena, N. K., & Anania, F. A. (2014) · The FASEB Journal · doi:10.1096/fj.14-253229 · Cited by 41
Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy
Omar, R., Yang, J., Liu, H., Davies, N. M., & Gong, Y. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2016_6 · Cited by 44
Insulin‐like growth factor binding protein‐related protein 1 contributes to hepatic fibrogenesis
Guo, X. H., Liu, L. X., Zhang, H. Y., Zhang, Q. Q., Li, Y., Tian, X. X., & Qiu, Z. H. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12126 · Cited by 39
Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis
Xia, S., Huang, Y., Zhang, Y., Zhang, M., Zhao, K., Han, P., Tian, D., Liao, J., & Liu, J. (2023) · European journal of medical research · doi:10.1186/s40001-023-01488-7 · Cited by 38
Shiha, G. E.-S., Abu‐Elsaad, N., Zalata, K. R., & Ibrahim, T. M. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12286 · Cited by 39
Charoensuk, L., Pinlaor, P., Wanichwecharungruang, S. P., Intuyod, K., Vaeteewoottacharn, K., Chaidee, A., Yongvanit, P., Pairojkul, C., Suwannateep, N., & Pinlaor, S. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.10.005 · Cited by 38
Duval, F., Moreno-Cuevas, J. E., González‐Garza, M. T., Rodriguez-Montalvo, C. A., & Cruz‐Vega, D. E. (2014) · Chinese Medicine · doi:10.1186/s13020-014-0027-4 · Cited by 39
Dong, D., Yin, L., Qi, Y., Xu, L., & Peng, J. (2015) · Nutrients · doi:10.3390/nu7064829 · Cited by 37
Quaglia, A., Alves, V. A. F., Balabaud, C. P., Bhathal, P. S., Bioulac‐Sage, P., Crawford, J. M., Dhillon, A. P., Ferrell, L. D., Guido, M., Hytiroglou, P., et al. (2016) · Histopathology · doi:10.1111/his.12957 · Cited by 36
Reversibility of Stricturing Crohnʼs Disease—Fact or Fiction?
Bettenworth, D., & Rieder, F. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000598 · Cited by 39
Yang, M.-C., Chang, C., & Lei, H.-Y. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.139 · Cited by 35
Promising therapies for treatment of nonalcoholic steatohepatitis
Noureddin, M., Zhang, A., & Loomba, R. S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1220533 · Cited by 37
Lee, Y., & Friedman, S. L. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00006-4 · Cited by 41
Dong, M. H., & Saab, S. (2008) · Disease-a-Month · doi:10.1016/j.disamonth.2008.03.006 · Cited by 34
Lukivskaya, O., Patsenker, E., Лис, Р. Е., & Buko, V. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01941.x · Cited by 34
Human Amnion Epithelial Cell Therapy for Chronic Liver Disease
Andrewartha, N., & Yeoh, G. C. (2019) · Stem Cells International · doi:10.1155/2019/8106482 · Cited by 36
Hepatic mast cell concentration directly correlates to stage of fibrosis in NASH
Lombardo, J. L., Broadwater, D. R., Collins, R., Cebe, K. M., Brady, R. O., & Harrison, S. A. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.11.029 · Cited by 35
A New Strategy for Treatment of Liver Fibrosis: Letting MicroRNAs Do the Job
Chen, S., Zheng, M., Shi, K., Yang, T., & Chen, Y. (2012) · BioDrugs · doi:10.1007/s40259-012-0005-2 · Cited by 35
Lin, X., Chen, Y., Lv, S., Tan, S., Zhang, S., Huang, R., Zhuo, L., Liang, S., Lu, Z., & Huang, Q. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.06.021 · Cited by 32
RetractedGrouix, B., Sarra‐Bournet, F., Leduc, M., Simard, J.-C., Hince, K., Geerts, L., Blais, A., Gervais, L., Laverdure, A., Felton, A., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250068 · Cited by 32
BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor.
Wang, L., Dong, J., Xiong, L., Shi, K., Zou, Z., Zhang, S., Cao, S.-T., Lin, Z., & Chen, Y. (2014) · PubMed Central · Cited by 31
Tan, Y., Li, Y., Zhou, F., Guo, J., Wang, T., Shi, Y., Yang, Y., Lu, J., & Pei, G. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.04.007 · Cited by 32
Choi, J. H., Hwang, Y. P., Park, B. H., Choi, C. Y., Chung, Y., & Jeong, H. G. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.10.011 · Cited by 30
Myofibroblast persistence with real-time changes in boundary stiffness
Kural, M. H., & Billiar, K. L. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.031 · Cited by 34
Tennakoon, A. H., Izawa, T., Wijesundera, K. K., Murakami, H., Katou-Ichikawa, C., Tanaka, M., Golbar, H. M., Kuwamura, M., & Yamate, J. (2014) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2014.09.008 · Cited by 29
Description of Prototype Modes-of-Action Related to Repeated Dose Toxicity
Landesmann, B., Paraskevi, G. M., Sharon, M., & Maurice, W. (2012) · Joint Research Centre (European Commission) · doi:10.2788/71112 · Cited by 33
Inhibitory effects of armepavine against hepatic fibrosis in rats
Weng, T., Shen, C., Chiu, Y.-T., Lin, Y., Kuo, C., & Huang, Y. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-78 · Cited by 30
Chen, P., Li, J., Huo, Y., Lu, J., Wan, L., Yang, Q., Huang, J., Gan, R., & Guo, C. (2016) · Scientific Reports · doi:10.1038/srep33593 · Cited by 33
A retrospective study of oral prednisolone treatment in canine chronic hepatitis
Favier, R. P., Poldervaart, J. H., van den Ingh, T. S. G. A. M., Penning, L. C., & Rothuizen, J. J. (2013) · Veterinary Quarterly · doi:10.1080/01652176.2013.826881 · Cited by 34
Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.
Papachrysos, N., Hytiroglou, P., Papalavrentios, L., Sinakos, E., Kouvelis, I., & Akriviadis, E. A. (2015) · PubMed Central · Cited by 35
Cai, S.-P., Cheng, X.-Y., Chen, P., Pan, X., Xu, T., Huang, C., Meng, X., & Li, J. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.11.002 · Cited by 28
Zhang, C., Liu, X., Sun, H., Meng, X., Bao, Y., Zhang, H.-P., Pan, F., & Zhang, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.005 · Cited by 28
Zhang, M., Liu, H., Huang, K., Peng, Y., Tao, Y., Zhao, C., Hu, X., & Liu, C. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8591892 · Cited by 31
Hepatic consequences of vascular adhesion protein-1 expression
Weston, C. J., & Adams, D. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0647-0 · Cited by 30
Kim, J. S., Koppula, S., Yum, M.-J., Shin, G. M., Chae, Y. J., Hong, S. M., Lee, J. D., & Song, M.-D. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1340965 · Cited by 26
Lee, J.-W., Kim, Y. I., Kim, Y., Choi, M., Min, S., Joo, Y. H., Yim, S., & Chung, N. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2997 · Cited by 27
XU, Q., Wang, J., Chen, F., Lin, K., Zhu, M., CHEN, L., Zhou, X., Li, C., & Zhu, H. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2603 · Cited by 26
Bai, G., Yan, G., Wang, G., Wan, P., & Zhang, R. (2016) · Oncology Reports · doi:10.3892/or.2016.5078 · Cited by 24
Kurtoğlu, E. L., Kayhan, B., Gül, M., Kayhan, B., Akdoğan, M., Karaca, Z. M., Yeşilada, E., & Yılmaz, S. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18276 · Cited by 25
Saeed, A. O., Baloch, K., Brown, R. J. P., Wallis, R., Chen, L., Dexter, L., McClure, C. P., Shakesheff, K. M., & Thomson, B. J. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12174 · Cited by 24
Rieder, F., Bettenworth, D., Imai, J., & Inagaki, Y. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000445135 · Cited by 27
Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells
Tien, Y., Wu, Y., Lin, W., Lee, M., & Lee, P. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.016 · Cited by 25
Intrahepatic NK cells function suppressed in advanced liver fibrosis
Li, X., Zhang, M., Liu, J., Huang, Z., Zhao, Q., Huang, Y., Li, X., & Gao, Z. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12669 · Cited by 27
Taneja, S., Tohra, S., Duseja, A. K., Dhiman, R. K., & Chawla, Y. K. (2016) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2016.08.001 · Cited by 26
Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review)
Cheng, Q.-N., Yang, X. Y., Wu, J., Ai, W., & Ni, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12003 · Cited by 24
Parajuli, D. R., Park, E., Che, X., Jiang, W., Kim, Y., Sohn, D. S., & Lee, S. (2013) · Molecules · doi:10.3390/molecules18022122 · Cited by 22
Khalifa, Y. H., Mourad, G. M., Stephanos, W. M., Omar, S. A. M., & Mehanna, R. A. (2019) · BioMed Research International · doi:10.1155/2019/5376165 · Cited by 23
Chong, L., Hsu, Y., Chiu, Y., Yang, K., & Huang, Y. (2011) · Phytotherapy Research · doi:10.1002/ptr.3381 · Cited by 22
Ding, X., Zhu, X., Xu, D., Li, S., Yang, Q., Feng, X., Wei, Y.-G., Li, H., Yang, L., Zhang, Y.-J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06043-0 · Cited by 22
Yang, X. F., Han, Z.-P., Zhang, S., Zhu, P.-X., Hao, C., Fan, T.-T., Yang, H. J., Li, L., Shi, Y.-F., & Wei, L.-X. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.257 · Cited by 22
Synthesis, characterization, and pharmacological evaluation of zinc oxide nanoparticles formulation
Hussain, Z., Khan, J. A., Anwar, H., Andleeb, N., Murtaza, S., Ashar, A., & Arif, I. (2018) · Toxicology and Industrial Health · doi:10.1177/0748233718793508 · Cited by 21
Chuang, H., Ng, L., Lin, L., Chang, J., Chen, J., Lin, T., & Lin, C. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4521 · Cited by 21
Role of the S100 protein family in liver disease (Review)
Yao, S., Yang, X., An, J., Jin, H. D., Wen, G., Wang, H., & Tuo, B. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4999 · Cited by 21
Chou, M.-H., Huang, Y., Lin, T., Du, Y.-Y., Tsai, P.-C., Hsieh, C., & Chuang, J. (2012) · Biochemical Journal · doi:10.1042/bj20112058 · Cited by 21
Nunes de Carvalho, S., Helal-Neto, E., de Andrade, D. C., Costa Cortez, E. A., Thole, A. A., Barja-Fidalgo, C., & de Carvalho, L. (2013) · Cells Tissues Organs · doi:10.1159/000353215 · Cited by 20
Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
Wu, M., Zhou, Y., Qin, S.-L., Lin, L., Jian, P., Zhang, T., Zhang, J., Xu, L., & Wu, J. H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3468791 · Cited by 20
Kaerophyllin inhibits hepatic stellate cell activation by apoptotic bodies from hepatocytes
Lee, T., Lin, Y., & Huang, Y. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02485.x · Cited by 19
Yum, M.-J., Koppula, S., Kim, J. S., Shin, G. M., Chae, Y. J., Yoon, T., Chun, C. S., Lee, J. D., & Song, M.-D. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1311928 · Cited by 19
Guo, Z.-R., Li, D., Peng, H., Kang, J., Jiang, X., Xie, X., Sun, D., & Jiang, H. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1322598 · Cited by 19
Wu, Y. M., Lu, S., Huang, X., Liu, Y., Huang, K., Liu, Z., Xu, W., Zhu, W., Hou, J., Liu, H., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120235 · Cited by 20
Zhang, M., Ye, Y., Wang, F., Zhu, J., Zhao, Q., Zheng, Y., Gu, Y., Xie, C., Huang, Z., Tai, Q., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-60 · Cited by 18
Amniotic Membrane and Its Derivatives: Novel Therapeutic Modalities in Liver Disorders
Arki, M., Moeinabadi-Bidgoli, K., Hossein-khannazer, N., Gramignoli, R., Najimi, M., & Massoud Vosough, M. P. (2023) · Cells · doi:10.3390/cells12162114 · Cited by 16
αvβ1 integrin as a novel therapeutic target for tissue fibrosis
Song, K., Cho, S.-J., & Song, J. Y. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.33 · Cited by 20
Fu, R., Wu, J., Ding, J., Sheng, J., Liang, H., Sun, Q., Fang, H., & Xiang, D. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010231 · Cited by 16
Genomic and Proteomic Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
Lee, N. P. Y., Cheung, S., Poon, R. T. P., Fan, S.-T., & Luk, J. M. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.2.273 · Cited by 16
Che, D. N., Shin, J. Y., Kang, H. J., Cho, B. O., Park, J. H., Wang, F., Hao, S., Sim, J. S., Sim, D. J., & Jang, S. I. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2548 · Cited by 15
Mousa, M. A. E. H., Mansour, H., Eid, F. A., & Mashaal, A. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13819 · Cited by 17
Luedde, T., & Trautwein, C. (2008) · Hepatology · doi:10.1002/hep.22232 · Cited by 15
TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells
Xu, D., Li, X., Li, Y., Liu, Y., Huang, C., Meng, X., & Li, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.178 · Cited by 14
Abdel-Latif, M. S. (2015) · The Open Microbiology Journal · doi:10.2174/1874285801509010136 · Cited by 14
Liver fibrosis: The hepatocyte revisited
Gorrell, M. D., & Kowdley, K. V. (2007) · Hepatology · doi:10.1002/hep.22003 · Cited by 14
Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis
Charchanti, A. V., Kanavaros, P., Koniaris, E., Kataki, A., Glantzounis, G. K., Agnantis, N. J., & GOUSSIA, A. C. (2021) · In Vivo · doi:10.21873/invivo.12264 · Cited by 16
Polaprezinc inhibits liver fibrosis and proliferation in hepatocellular carcinoma
Ye, J., Zhang, Z., Zhu, L. W., Lu, M., Li, Y., Zhou, J., Lu, X., & Du, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7262 · Cited by 14
Zhang, M., Wang, F., Zhu, J., Zheng, Y., Zhao, Q., GU, Y.-R., Zhang, Q., Chong, Y., & Gao, Z. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.767 · Cited by 13
Lee, S. H., Zhao, Y., Park, E., Che, X., Seo, G. S., & Sohn, D. H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.067 · Cited by 13
Regenerative toxicology: the role of stem cells in the development of chronic toxicities
Canovas-Jorda, D., Louisse, J., Pistollato, F., Zagoura, D., & Bremer, S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.844228 · Cited by 13
Hepatic Fibrosis and Cirrhosis
Rockey, D. C., & Friedman, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00005-x · Cited by 22
A Review of Liver Fibrosis and Emerging Therapies
Nathwani, R., Mullish, B. H., Koeckerling, D., Forlano, R., Manousou, P., & Dhar, A. (2020) · European Medical Journal · doi:10.33590/emj/10310892 · Cited by 14
Kim, K., Lee, J. I., Kim, O., Hong, H., Kwak, B. J., Choi, H. J., Ahn, J., Lee, T. Y., Lee, S. C., & Kim, S. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i11.990 · Cited by 13
Phaosri, M., Jantrapirom, S., Takuathung, M. N., Soonthornchareonnon, N., Sireeratawong, S., Buacheen, P., Pitchakarn, P., Nimlamool, W., & Potikanond, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246314 · Cited by 13
Ma, L., Ma, J., & Hong-liang, O. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9787 · Cited by 16
Arthanari, S., Periyasamy, P., & Jang, H. T. (2019) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2019.101040 · Cited by 14
Wanless, I. R. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch4 · Cited by 12
Pu, T.-Y., Chuang, K.-C., Tung, M., Yen, C., Chen, Y., Cidem, A., Ko, C.-H., Chen, W., & Chen, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116490 · Cited by 13
Ding, Z., Kng, Y. L., Yang, H. H., Ke, Z., & Zhuo, L. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.11 · Cited by 11
Influencing factors of transient elastography in detecting liver stiffness
Shan, R., Yin, H. X., Yang, W., Li, J., Zhang, M., Zhao, M., Shao, J., & Wang, A. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3617 · Cited by 11
Molecular targets in the design of antifibrotic therapy in chronic liver disease.
Herruzo, J. A. S., Solís‐Muñoz, P., Yagüe, T. M., & García‐Ruíz, I. (2011) · PubMed · Cited by 11
Vascular Disorders of the Liver
Wanless, I. R. (2009) · Elsevier eBooks · doi:10.1016/b978-141604059-0.50046-1 · Cited by 10
Molecular aspects of hepatic encephalopathy
Márquez-Aguirre, A. L., Canales-Aguirre, A. A., Gómez‐Pinedo, U., & Gálvez-Gastélum, F. J. (2010) · Neurología (English Edition) · doi:10.1016/s2173-5808(10)70048-1 · Cited by 9
Karaca, Z. M., Kurtoğlu, E. L., Gül, M., & Kayhan, B. (2022) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2022.20030 · Cited by 9
Interacciones patogénicas entre alcohol y hepatitis C
Fuster, D., Tor, J., Rey‐Joly, C., & Muga, R. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.04.019 · Cited by 10
Metadata
- Authors
- Henderson, N. C., & Iredale, J. P.
- Affiliations
- Centre for Inflammation Research (GB)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2007-02-01
- Volume
- 112
- Issue
- 5
- Pages
- 265-280
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1976809932
- Cited by
- 270
- References
- 139
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 15 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 13 · 2016: 23 · 2015: 25 · 2014: 19 · 2013: 15 · 2012: 20
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- liver fibrosis, fibrosis resolution, myofibroblasts, hepatic stellate cells, wound healing, innate immune response, adaptive immune response, antifibrotic therapy, transgenic animal models, lineage tracing, bone marrow-derived stem cells, liver regeneration
- MeSH terms
- Animals, Disease Models, Animal, Fibroblasts, Humans, Immunity, Cellular, Liver Cirrhosis, Prognosis, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.